ACKGROUND: ALDH1A1 and ALDH1A3, the most renowned isozymes of aldehyde dehydrogenase (ALDH)1, are important in regulating the pluripotency of human mesenchymal stem cells (MSCs) and cancer stem cells (CSCs). The study aimed to analyze the mRNA expression of ALDH1A1 and ALDH1A3 genes in adipose stem cells (ASCs) and umbilical cord stem cells (UCSCs) along with their correlations to Oct-4 mRNA expression. Additionally, the interaction between these proteins was also investigated using in silico study to confirm the pluripotency of both MSCs compared to human breast ALDH + CSCs.
Introduction
Human aldehyde dehydrogenase (ALDH), a superfamily consisting of 19 isoforms, plays important role in irreversible oxidation of acetaldehyde.(1,2) ALDH1A1 and ALDH1A3 belong to ALDH1A subfamily which have been suggested to play important role in retinoic signaling pathway. (1, 3) Acting as a detoxification enzyme, both ALDH1A1 and ALDH1A3 catalyze the oxidation of retinal to retinoic acid, contributing to the characteristic of selfprotection in stem cells. (1, 4) Moreover, they also influence the stemness regulation in terms of cell proliferation and differentiation. (3, 4) Mesenchymal stem cells (MSCs) can be abundantly obtained from human adult tissues (5-7) and share common characteristics which include being plastic-adherent when maintained in standard culture condition, have multipotent capacity to differentiate into osteoblasts, adipocytes, and chondroblasts in vitro, while still express cluster of differentiation (CD)73, CD90, and CD105, with lack of CD14, CD19, CD45, CD34 and human leukocyte antigen-DR isotype (HLA-DR) expression. (8) Recently, MSCs have been widely used in regenerative medicine. Among various kinds of MSCs, there are adipose-derived stem cells (ASCs) and umbilical cord stem cells (UCSCs) which are recently reported as preferable options for stem cell therapy. (6, 9, 10) This fact is due to their advantages over bone marrowderived stem cells such as being able to be obtained noninvasively with minimal immunological and ethical issues. (6, 11) UCSCs are stem cells which can be obtained from total umbilical cord or various sections of umbilical cord, comprising Wharton's jelly, and subendothelial layer of both umbilical arteries and umbilical vein excluding its inner blood vessel walls. (9, 12) On the other hand, ASCs are stem cells which are retrieved from adipose tissue. (7, 13) Aside from having the common characteristics of MSCs, UCSCs and ASCs can be differentiated in terms of proliferation ability and differentiation capability. It has been reported that UCSCs have higher proliferation ability compared to ASCs, while ASCs are more adipogenic than UCSCs. (14) Cancer stem cells (CSCs) have been reported to be responsible for initiation and maintenance of cancer due to their self-renewal, pluripotency, and tumorigenic properties, similar to normal stem cells. (15) Regarding the fact that ALDH1A1 and ALDH1A3 are found in both normal and cancer stem cells, the specific role of these genes in the aspect of stemness, especially pluripotency, remains unclear. Therefore, this study aimed to analyze the expression of ALDH1A1 and ALDH1A3 genes in ASCs and UCSCs relatively to human breast ALDH + CSCs; along with the confirmation of its pluripotency when being compared to Oct-4 relative expression in both stem cells. 
Methods

Stem Cell Specimens
Primer Design
Primers for ALDH1A1, ALDH1A3 and Oct-4 were obtained from previous study done by Purnamawati, et al.(17) The primers are listed in Table 1 . The qRT-PCR is done in triplicate in the following sequence: cDNA synthesis for 5 minutes at 42°C, inactivation of reverse transcriptase for 5 minutes at 95°C, 40 cycles consisting of denaturation of double stranded DNA for 30 seconds at 95°C and gene annealing for 20 seconds at different optimized temperatures for each genes (Table 1) , and elongation for 20 seconds at 72°C.
RNA Isolation and
The measured gene expression was recorded in Cq, and the values were then normalized to the respective gene expression in ALDH + breast CSCs and 18S rRNA gene as reference. Furthermore, melting curve analysis was also performed for each sample to evaluate the authenticity of the products.
Electrophoresis
To verify the PCR products, 2% agarose gel electrophoresis was performed and visualized using GelRed stain (Biotium, Hayward, California, USA).
Bioinformatic Analysis
To further explore the gene expression data, we conducted in silico protein-protein interaction analysis using the Search Tool for the Retrieval of Interacting Genes (STRING 9.1) database. This software associates high throughput experiment data from database mining and literature, as well as from predictions based on genomic context analysis.
Statistical Analysis
Data are shown in relative expression±standard error. Statistical differences between two groups were analyzed using SPSS Software Version 20.0.0.0 by Independent T-Test, considering the p-value<0.05 is statistically significant.
Results
ALDH1A1 mRNA Expression Level in ASCs and UCSCs
To investigate the expression of ALDH1A1, qRT-PCR was conducted in ASCs and UCSCs. Single-peak melting curve was obtained from this PCR, suggesting that the amplified gene is indeed the gene of interest (ALDH1A1). Figure 1 depicts that ALDH1A1 gene was expressed significantly higher in ASCs than UCSCs when being normalized to breast CSCs (p=0.01). Furthermore, this result also points out the lower expression of ALDH1A1 in MSCs (ASCs and UCSCs) compared to ALDH + breast CSCs.
ALDH1A3 mRNA Expression Level in ASCs and UCSCs
Similar to ALDH1A1, ALDH1A3 gene expression was measured by conducting qRT-PCR in both ASCs and UCSCs samples. The quality of ALDH1A3 RT-PCR was measured using its single-peak melting curve. In the study, it was found that ALDH1A3 was expressed at similar level in ASCs and UCSCs (p=0.275), as depicted in Figure 2 . Additionally, in contrast to ALDH1A1, ALDH1A3 expression in both MSCs was higher than those expressed in ALDH + breast CSCs.
Oct-4 mRNA Expression Level in ASCs and UCSCs
To explore whether there were any differences between ASCs and UCSCs in the aspect of pluripotency, Oct-4 expression was also measured by RT-PCR. The melting curve analysis of Oct-4 RT-PCR results points out a single peak, suggesting that the amplified gene si indeed Oct-4. Figure 3 shows that there was no significant difference between ASCs and UCSCs in terms of Oct-4 expression (p=0.827). Moreover, Oct-4 is expressed significantly lower in MSCs compared to CSCs, in line with the expression of ALDH1A1.
ALDH1A1, ALDH1A3 and Oct-4 Protein-Protein Interactions
The result of the in silico analysis, as depicted in Figure 4 , indicates that there is a potential proteinprotein interaction between ALDH1A1 and pluripotency markers (POU class 5 homeobox 1 (POU5F1) (Oct-4), sex determining region Y-box 2 (SOX2), nanog homeobox (NANOG), and Kruppel-like factor 4 (KLF4)). ALDH1A3 interacts with ALDH1A1 through alcohol dehydrogenases (ADH4 and ADH1A). This result is in accordance to the fact that these four proteins belong to group of proteins which functions in intracellular detoxification mechanisms. However, the interaction between ALDH1A3 and aforementioned pluripotency markers remains unclear. The present study measures mRNA levels of ALDH1A1 and ALDH1A3 to investigate the synthesis of these genes. We observed higher expression level of ALDH1A1 in ASCs compared to UCSCs. This finding supports the previous study performed by Kiefer FW, et al., which stated that ALDH1A1 expression can be dominantly found in adipose tissue, especially White Adipose Tissue (WAT). (18) Greater ALDH1A1 expression in ASCs suggests that ALDH1A1 might contribute to certain properties which differ ASCs from UCSCs such as proliferation and adipogenic differentiation capability. (19, 20) In contrast to ALDH1A1, ALDH1A3 was expressed in ASCs and UCSCs at similar levels. Albeit previous studies have reported that both ALDH1A1 and ALDH1A3 are expressed in MSCs (2,3), our results, for the first time, showed that ALDH1A1 expression is related to different sources of MSCs while ALDH1A3 expression is not.
Interestingly, ALDH1A1 expression in both ASCs and UCSCs is much lower than in human ALDH + breast CSCs. Different expressions in MSCs and CSCs might be due to lower pluripotency of MSCs compared to CSCs which is caused by uncontrolled proliferation capability acquired by CSCs after repeated gene mutations. Nevertheless, ALDH1A1 contributes in a similar way to the pluripotent of both MSCs and CSCs, through Wnt pathway. (21) (22) (23) Similarly, Oct-4 mRNA was expressed greater in CSCs than MSCs. This finding emphasized similar trend of ALDH1A1 and Oct-4 gene expressions, which is best expressed by positive correlation between both genes. Hence, since this research studied the regulation of mRNA synthesis of each gene, this parallel findings between ALDH1A1 and Oct-4 mRNA expression propose the possibility these genes could be expressed due to similar regulatory factors as the stimulation.
In contrast to ALDH1A1 and Oct-4, our study emphasizes that ALDH1A3 is found in a higher level in MSCs than in CSCs. This suggests that ALDH1A3 plays a more significant role in MSCs than in CSCs and has little or no contribution to the pluripotency of stem cells and CSCs. Purnamawati, et al., found that the expression of ALDH1A3 is consistent with TGF-b1 which plays a role in inhibiting cell proliferation, cell motility, invasion, and metastasis. (24) This finding is also supported by previous study by Crocker, et al., which stated that unlike ALDH1A1, ALDH1A3 is found to have no effect on the proliferation of human breast CSCs.(25) Our result obtained from in silico analysis confirms that in contrast to ALDH1A1, ALDH1A3 was found not to interact directly to the pluripotency markers, Oct-4, SOX2, NANOG, and KLF4. Further studies are required to elaborate the specific role of ALDH1A3 in MSCs. From these findings, it can be inferred that ASCs and UCSCs express different levels of ALDH1A1 and ALDH1A3. This implies on the application of MSCs, such as in the use of ASCs in fat grafting of breast reconstruction after breast cancer surgery (26) and UCSCs in tissue engineering. (5, 27) Different usage of stem cells in clinical settings might be due to various differentiation capacities that they possess. ASCs show excellent differentiation and clonal ability to adipose tissue. (28, 29) Meanwhile, UCSCs present outstanding capability in differentiating to cardiomyocyte, fibrocartilage tissue, or even collagen, making it suitable to be used in tissue engineering. (9, 12) Nevertheless, several reports have shown the possibility of cancer recurrence post-ASCs fat grafting. (30, 31) Mazur has reported the cancer recurrence in 3.7% patients treated with ASC-enriched fat. Although it is not differ significantly to the control group (4.13%), the recurrence might be caused by the pro-angiogenesis and adipogenesis capabilities from ASCs, which support the survival of neighboring malignant cells. (32, 33) Knowing these facts, it is prudent to consider other type of MSCs to be used in fat grafting of breast reconstruction after breast cancer surgery. However, little studies have been performed to study the benefits of UCSCs in fat grafting. This condition might be due to the difficulty in provision of appropriate MSCs number, which is not usually adequate to be used in major clinical disorders. (34) This study measures the mRNA expression to investigate the synthesis of the respective genes. Thus, to further ensure the pluripotency and specific roles of each gene in stem cells, it is recommended to conduct further research to investigate more on the role of the proteins of these genes in ASCs and UCSCs.
Conclusion
Taken together, we conclude that ALDH1A1 and ALDH1A3 were distinctly expressed in UCSCs and ASCs which might be associated with unique properties of the aforementioned stem cells. The distinct properties of ASCs and UCSCs are important to be taken into account in the application of both of the MSCs, particularly in stem cell therapy.
